Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Drug-Eluting Stents Market Report by Coating (Polymer Based Coating, Polymer Free Coating), Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, and Others), Stent Platform (Stainless-steel, Cobalt-Chromium, Platinum-Chromium, Nitinol, and Others), Generation (1st Generation, 2nd Generation, 3rd Generation, 4th Generation), Application (Coronary Artery Disease, Peripheral Artery Disease), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A4815
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug-Eluting Stents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Coating
6.1 Polymer Based Coating
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Polymer Free Coating
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug
7.1 Sirolimus
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Paclitaxel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Zotarolimus
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Everolimus
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Biolimus
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Stent Platform
8.1 Stainless-steel
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cobalt-Chromium
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Platinum-Chromium
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Nitinol
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Generation
9.1 1st Generation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 2nd Generation
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 3rd Generation
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 4th Generation
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Application
10.1 Coronary Artery Disease
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Peripheral Artery Disease
10.2.1 Market Trends
10.2.2 Market Forecast
11 Market Breakup by End User
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Ambulatory Surgical Centers
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia-Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 Abbott Laboratories
17.3.1.1 Company Overview
17.3.1.2 Product Portfolio
17.3.1.3 Financials
17.3.1.4 SWOT Analysis
17.3.2 B. Braun Melsungen AG
17.3.2.1 Company Overview
17.3.2.2 Product Portfolio
17.3.2.3 SWOT Analysis
17.3.3 Biosensors International Group Ltd.
17.3.3.1 Company Overview
17.3.3.2 Product Portfolio
17.3.4 Biotronik
17.3.4.1 Company Overview
17.3.4.2 Product Portfolio
17.3.4.3 SWOT Analysis
17.3.5 Boston Scientific Corporation
17.3.5.1 Company Overview
17.3.5.2 Product Portfolio
17.3.5.3 Financials
17.3.5.4 SWOT Analysis
17.3.6 Cardinal Health Inc.
17.3.6.1 Company Overview
17.3.6.2 Product Portfolio
17.3.6.3 Financials
17.3.6.4 SWOT Analysis
17.3.7 Cook Medical LLC (Cook Group Incorporated)
17.3.7.1 Company Overview
17.3.7.2 Product Portfolio
17.3.7.3 SWOT Analysis
17.3.8 Lepu Medical Technology (Beijing) Co. Ltd.
17.3.8.1 Company Overview
17.3.8.2 Product Portfolio
17.3.8.3 Financials
17.3.9 Medtronic plc
17.3.9.1 Company Overview
17.3.9.2 Product Portfolio
17.3.9.3 Financials
17.3.9.4 SWOT Analysis
17.3.10 MicroPort Scientific Corporation
17.3.10.1 Company Overview
17.3.10.2 Product Portfolio
17.3.11 Sino Medical Sciences Technology Inc.
17.3.11.1 Company Overview
17.3.11.2 Product Portfolio
17.3.12 Terumo Corporation
17.3.12.1 Company Overview
17.3.12.2 Product Portfolio
17.3.12.3 Financials
17.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2023
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2023
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2023
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2023
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2023
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2023
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2023
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2018 & 2023
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2023
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2024-2032
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2024-2032
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2024-2032
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2024-2032
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More